CN107014936B - 尿液中褪黑素硫酸盐的检测方法 - Google Patents
尿液中褪黑素硫酸盐的检测方法 Download PDFInfo
- Publication number
- CN107014936B CN107014936B CN201710340487.1A CN201710340487A CN107014936B CN 107014936 B CN107014936 B CN 107014936B CN 201710340487 A CN201710340487 A CN 201710340487A CN 107014936 B CN107014936 B CN 107014936B
- Authority
- CN
- China
- Prior art keywords
- phase
- mobile phase
- urine
- sample
- column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title claims abstract description 64
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title claims abstract description 64
- 229960003987 melatonin Drugs 0.000 title claims abstract description 63
- 210000002700 urine Anatomy 0.000 title claims abstract description 58
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims abstract description 37
- 238000001514 detection method Methods 0.000 claims abstract description 45
- 239000012086 standard solution Substances 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 239000008367 deionised water Substances 0.000 claims abstract description 9
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 9
- 238000000926 separation method Methods 0.000 claims abstract description 8
- 238000010790 dilution Methods 0.000 claims abstract description 3
- 239000012895 dilution Substances 0.000 claims abstract description 3
- 150000002500 ions Chemical class 0.000 claims description 56
- 239000000126 substance Substances 0.000 claims description 29
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- 238000004458 analytical method Methods 0.000 claims description 25
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 12
- 238000010828 elution Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 238000005173 quadrupole mass spectroscopy Methods 0.000 claims description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 235000019253 formic acid Nutrition 0.000 claims description 6
- DRLFMBDRBRZALE-NZLXMSDQSA-N n-[1,1,2,2-tetradeuterio-2-(5-methoxy-1h-indol-3-yl)ethyl]acetamide Chemical compound C1=C(OC)C=C2C(C([2H])([2H])C([2H])(NC(C)=O)[2H])=CNC2=C1 DRLFMBDRBRZALE-NZLXMSDQSA-N 0.000 claims description 6
- 239000002699 waste material Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000012544 monitoring process Methods 0.000 claims description 4
- 238000002552 multiple reaction monitoring Methods 0.000 claims description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 3
- 239000005695 Ammonium acetate Substances 0.000 claims description 3
- 235000019257 ammonium acetate Nutrition 0.000 claims description 3
- 229940043376 ammonium acetate Drugs 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000000132 electrospray ionisation Methods 0.000 claims description 3
- 238000001819 mass spectrum Methods 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 238000011084 recovery Methods 0.000 abstract description 13
- 230000035945 sensitivity Effects 0.000 abstract description 11
- 230000004907 flux Effects 0.000 abstract description 6
- 239000000523 sample Substances 0.000 description 51
- 238000012360 testing method Methods 0.000 description 7
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- JWUBBDSIWDLEOM-XHQRYOPUSA-N (3e)-3-[(2e)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2\C1=C\C=C1/CC(O)CCC1=C JWUBBDSIWDLEOM-XHQRYOPUSA-N 0.000 description 3
- 235000021318 Calcifediol Nutrition 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 210000004560 pineal gland Anatomy 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000004780 2D liquid chromatography Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- -1 indole heterocyclic compounds Chemical class 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- 238000012418 validation experiment Methods 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000004185 hypothalamic-pituitary-gonadal axis Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/08—Preparation using an enricher
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
Abstract
Description
被分析物 | Q1母离子(m/z) | Q3子离子(m/z) |
褪黑素硫酸盐 | 329.2 | 190 |
褪黑素硫酸盐内标 | 327.1 | 178.1 |
相对丰度(K) | K≥50% | 20%≤K≤50% | 10%≤K≤20% | K≤10% |
最大允许误差 | ±20% | ±25% | ±30% | ±50% |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710340487.1A CN107014936B (zh) | 2017-05-15 | 2017-05-15 | 尿液中褪黑素硫酸盐的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710340487.1A CN107014936B (zh) | 2017-05-15 | 2017-05-15 | 尿液中褪黑素硫酸盐的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107014936A CN107014936A (zh) | 2017-08-04 |
CN107014936B true CN107014936B (zh) | 2020-04-07 |
Family
ID=59449811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710340487.1A Active CN107014936B (zh) | 2017-05-15 | 2017-05-15 | 尿液中褪黑素硫酸盐的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107014936B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112816567A (zh) * | 2020-10-12 | 2021-05-18 | 深圳芙莱特营养与健康有限公司 | 测定褪黑素和维生素b6的高效液相色谱分析方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006012171A1 (de) * | 2006-03-14 | 2007-09-20 | Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. | Verfahren und Testbestecks zur Bestimmung von neuroendokrinen gesundheitlichen Störungen |
CN105891364A (zh) * | 2016-04-11 | 2016-08-24 | 北京洛奇临床检验所股份有限公司 | 高效液相色谱串联质谱技术检测唾液中褪黑素的方法及试剂盒 |
CN106198784A (zh) * | 2016-06-28 | 2016-12-07 | 扬州大学 | 一种高效、准确检测芍药中褪黑素含量的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005300358A (ja) * | 2004-04-12 | 2005-10-27 | Shiseido Co Ltd | 高速液体クロマトグラフィー装置 |
-
2017
- 2017-05-15 CN CN201710340487.1A patent/CN107014936B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006012171A1 (de) * | 2006-03-14 | 2007-09-20 | Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. | Verfahren und Testbestecks zur Bestimmung von neuroendokrinen gesundheitlichen Störungen |
CN105891364A (zh) * | 2016-04-11 | 2016-08-24 | 北京洛奇临床检验所股份有限公司 | 高效液相色谱串联质谱技术检测唾液中褪黑素的方法及试剂盒 |
CN106198784A (zh) * | 2016-06-28 | 2016-12-07 | 扬州大学 | 一种高效、准确检测芍药中褪黑素含量的方法 |
Non-Patent Citations (4)
Title |
---|
A novel LC–MS/MS assay for the simultaneous determination of melatonin and its two major metabolites, 6-hydroxymelatonin and 6-sulfatoxymelatonin in dog plasma: Application to a pharmacokinetic study;Huimin Zhao et al.;《Journal of Pharmaceutical and Biomedical Analysis》;20151228;第117卷;390–397页 * |
Anna Maria Sniecinska-Cooper et al..Determination of urinary cortisol, cortisone and 6-sulfatoxymelatonin using dilute and shoot ultra-high pressure liquid chromatography–tandem mass spectrometry.《Journal of Chromatography B》.2014,"ABSTRACT",第19-21页第2-3节. * |
Determination of urinary cortisol, cortisone and 6-sulfatoxymelatonin using dilute and shoot ultra-high pressure liquid chromatography–tandem mass spectrometry;Anna Maria Sniecinska-Cooper et al.;《Journal of Chromatography B》;20141203;"ABSTRACT",第19-21页第2-3节 * |
褪黑激素的高效液相色谱分析;陈伟 等;《药学进展》;19971231;第21卷;164-168页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107014936A (zh) | 2017-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103308621B (zh) | 高通量液相色谱法串联质谱法检测25羟基维生素d的方法 | |
Li et al. | Simultaneous determination of clenbuterol, salbutamol and ractopamine in milk by reversed-phase liquid chromatography tandem mass spectrometry with isotope dilution | |
CN106526026B (zh) | 血清中25-羟基维生素d的检测方法 | |
US8487241B2 (en) | Methods for detecting catecholamines by mass spectrometry | |
CN104215716B (zh) | 一种检测人血清中总睾酮的方法 | |
EP3356831B1 (en) | Amyloid beta detection by mass spectrometry | |
CN110243977B (zh) | 检测血清中四种孕激素的方法 | |
US11624737B2 (en) | Methods for detecting lacosamide by mass spectrometry | |
CN112014509A (zh) | 同步测定样品中血管紧张素i和醛固酮的方法 | |
CN107014936B (zh) | 尿液中褪黑素硫酸盐的检测方法 | |
CN110702829B (zh) | 一种测定血浆或血清中醛固酮含量的方法 | |
CN113155991A (zh) | 一种全自动在线萃取超高效液相色谱串联质谱联用快速测定水中磺胺类抗生素的方法 | |
Eysseric et al. | Post-column hydrogen–deuterium exchange technique to assist in the identification of small organic molecules by mass spectrometry | |
CN103293268A (zh) | 一种人尿氢化可的松的检测方法 | |
Yeung et al. | Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring | |
CN111148998A (zh) | 通过质谱法进行的载脂蛋白e同种型检测 | |
Chen et al. | High throughput proteomics enabled by a fully automated dual-column liquid chromatography system coupled with mass spectrometry | |
CN111337597A (zh) | 一种快速检测血浆中他达拉非浓度的方法 | |
WO2023196587A1 (en) | Detection of insulin-like growth factor-2 variants by mass spectrometry | |
CN116642975A (zh) | 一种六项儿茶酚胺类激素质谱检测方法及其应用 | |
CN114858570A (zh) | 一种直接用于血药浓度监测的样本前处理系统及方法 | |
CN116735761A (zh) | 一种人血浆中布立西坦的uplc-ms/ms检测方法 | |
CN111650313A (zh) | 定量测定生物样品中利拉鲁肽生物类似物含量的方法 | |
Ngo | Development of an analytical method for vinca alkaloids using liquid chromatography/tandem mass spectrometry (LC/MS/MS) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 510663 Guangdong province Guangzhou Science City, Guangzhou hi tech Industrial Development Zone, No. 31 building G1 room 701 Ke Feng Lu Applicant after: Guangzhou Bohou Health Technology Co.,Ltd. Address before: 510663 Guangdong province Guangzhou Science City, Guangzhou hi tech Industrial Development Zone, No. 31 building G1 room 701 Ke Feng Lu Applicant before: BIOHOP HEALTH TECHNOLOGIES CO.,LTD. |
|
CB02 | Change of applicant information |
Address after: 510700 Room 501, Building G7, 31 Kefeng Road, Huangpu District, Guangzhou City, Guangdong Province Applicant after: Guangzhou Bohou Health Technology Co.,Ltd. Address before: 510663 Guangdong province Guangzhou Science City, Guangzhou hi tech Industrial Development Zone, No. 31 building G1 room 701 Ke Feng Lu Applicant before: Guangzhou Bohou Health Technology Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for detecting melatonin sulfate in urine Effective date of registration: 20230414 Granted publication date: 20200407 Pledgee: China Construction Bank Corporation Guangzhou Development Zone Branch Pledgor: Guangzhou Bohou Health Technology Co.,Ltd. Registration number: Y2023980038135 |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 510000 Room 501, building G7, 31 Kefeng Road, Huangpu District, Guangzhou City, Guangdong Province Patentee after: BIOHOP HEALTH TECHNOLOGIES CO.,LTD. Address before: 510700 Room 501, building G7, 31 Kefeng Road, Huangpu District, Guangzhou City, Guangdong Province Patentee before: Guangzhou Bohou Health Technology Co.,Ltd. |